Perrigo Recalls Option 2 Emergency Contraceptive Tablets Due to Missing Blister
L. Perrigo Company is recalling Option 2 emergency contraceptive tablets because some cartons are missing the tablet blister strip and tablet.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the hazard is a packaging defect (missing tablet) rather than a contamination or labeling error that poses a direct health risk, fitting the 'Moderate' criteria for minor labeling/packaging issues.
Plain-English summary
L. Perrigo Company is recalling specific lots of Option 2 (levonorgestrel) 1.5 mg emergency contraceptive tablets. The recall is due to a defective container issue where the carton is missing the tablet blister strip and the tablet itself.
The affected product is distributed nationwide in the US and Canada. The specific lots involved are 6LV1114, 6LV1115, 6LV1116, 6MV0976, 6MV0977 (expiring 04/18) and 7AV1173, 7AV1175, 7AV1176 (expiring 07/18). The total quantity recalled is 181,776 units.
Consumers should check their Option 2 packages for the lot numbers and expiration dates listed above. If the package matches the recalled lots, consumers should contact L. Perrigo Company for further instructions or a replacement.
The recalled product
- Product
- OPTION 2 (LEVONORGESTREL)
- Brand
- OPTION 2
- Manufacturer
- L. Perrigo Company
- Category
- Drug — Emergency Contraceptive
- Hazard
- Affected units
- 181,776
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot #: 6LV1114
- 6LV1115
- 6LV1116
- 6MV0976
- 6MV0977
- Exp.04/18
- 7AV1173
- 7AV1175
- 7AV1176
- Exp.07/18.
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · L. Perrigo Company
See all →- HighFexofenadine Hydrochloride Tablets Recalled for Failed Purity Specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Allergy Relief Tablets Recalled for Failed Manufacturing Specifications
FDA (Drugs) · 2023-07-19
- HighBASIC CARE Allergy Tablets Recalled Due to Failed Quality Specifications
FDA (Drugs) · 2023-07-19
- HighAllergy Relief Fexofenadine Tablets Recalled for Failed Impurity Specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Antihistamine Tablets Recalled for Failed Quality Specifications
FDA (Drugs) · 2023-07-19
Same hazard · packaging defect
See all →- HighEmbosphere Microspheres Recalled Due to Packaging Sterility Concerns
FDA (Devices) · 2026-10-07
- ModerateAmneal Recalls Estradiol Gel Packets Due to Empty or Partially Full Containers
FDA (Drugs) · 2026-10-07
- HighCardinal Health Recalls Presource Convenience Kits Due to Seal Defects
FDA (Devices) · 2026-09-30
- ModerateAVID Medical Recalls Halyard IV Start Kits Due to Packaging Seal Issues
FDA (Devices) · 2026-09-30
- HighCardinal Health Recalls Presource Convenience Kits Due to Potential Seal Defects
FDA (Devices) · 2026-09-30
Similar recalls
- ModerateWatson Recalls Next Choice Emergency Contraceptive Tablets Due to Breakage
FDA (Drugs) · 2013-10-16
- LowTeva Recalls Jolessa Contraceptive Tablets Due to Missing Placebo Tablets
FDA (Drugs) · 2012-06-27
- ModerateLupin Recalls My Way Emergency Contraception Tablets for Lack of Approval
FDA (Drugs) · 2018-05-30
- LowTeva Recalls Portia Tablets Due to Appearance Specification Failures
FDA (Drugs) · 2013-04-17
- ModerateLupin Recalls My Way Levonorgestrel Tablets for Lack of Approved NDA
FDA (Drugs) · 2018-05-30
- LowTeva Recalls Jolessa Tablets Due to Appearance Specification Failures
FDA (Drugs) · 2013-04-17